The total prevalent cases of chronic kidney disease (CKD) were 103,485,844 cases in 2021 in the 7 major markets (7MM). The number of cases is expected to increase at an annual growth rate (AGR) of more than 1% during the forecast period. Chronic kidney disease or chronic renal disease, is a condition characterized by a gradual loss of kidney function over time. This leads to the accumulation of excess fluid and waste in the body. In the early stages, chronic kidney disease is a largely asymptomatic condition. As the disease progresses, the symptoms worsen and eventually lead to kidney failure.

The chronic kidney disease market research report provides an overview of the risk factors, comorbidities, and global and historical trends for CKD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It also includes a 10-year epidemiological forecast for total prevalent cases and diagnosed prevalent cases of CKD. The total and diagnosed prevalent cases of CKD are further segmented by age, sex, and stage in these markets.

Chronic Kidney Disease Market Overview

To gain more information on the chronic kidney disease market forecast, download a free report sample

What are the key age segments in the chronic kidney disease market?

The chronic kidney disease market can be segmented based on age into 18-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and above 80 years.

In 2021, for the 7MM combined, adults ages 70–79 years contributed the highest proportion of the diagnosed prevalent cases of chronic kidney disease followed by the age group 60–69 years and ages 80 years and older.

Chronic Kidney Disease Market Analysis by Age

For more age segment insights, download a free report sample

What are the key sex segments in the chronic kidney disease market?

The chronic kidney disease market can be segmented based on sex into men and women.

In the 7MM combined, the number of diagnosed prevalent cases of CKD was higher in women than in men in 2021. However, in Germany and Japan, the number of diagnosed prevalent cases of CKD was observed to be higher in men than in women. France had the smallest variation in the number of diagnosed prevalent cases between men and women.

Chronic Kidney Disease Market Analysis by Sex

For more sex segment insights, download a free report sample

What are the key stages in the chronic kidney disease market?

The chronic kidney disease market can be further divided into six stages: stage I, stage II, stage IIIa, stage IIIb, stage IV, and stage V.

In the 7MM, the highest number of diagnosed prevalent cases of CKD was in stage IIIa followed by stages IIIb and stage II. Among the 7MM, Japan had the highest number of diagnosed prevalent cases of CKD in stage IIIa followed by the US. This difference in stage-specific diagnosed prevalent cases might be driven by the varying stage-specific diagnosis rate in the markets.

Chronic Kidney Disease Market Analysis by Stages

For more stage insights, download a free report sample

What are the key dialysis dependence types in the chronic kidney disease market?

The chronic kidney disease market can be divided into two types based on dialysis dependence: non-dialysis dependent and dialysis dependent.

In the 7MM, the US had the highest number of diagnosed prevalent cases of CKD that were non-dialysis dependent followed by Japan and Germany. For dialysis-dependent CKD, the US had the highest number of diagnosed prevalent cases followed by Japan and Germany.

Chronic Kidney Disease Market Analysis by Dialysis Dependence

For more insights on dialysis dependence types, download a free report sample

Which are the 7 major markets (7MM) in the chronic kidney disease market?

The 7 major markets in chronic kidney disease are the US, France, Germany, Italy, Spain, the UK, and Japan.

It is expected that, in 2031, the US will have the highest number of diagnosed prevalent cases of CKD in the 7MM and Italy will have the fewest diagnosed prevalent cases of CKD.

Market Report Scope

Scope

• The Chronic Kidney Disease Epidemiology Report and Model provide an overview of the risk factors and global trends of CKD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report includes a 10-year epidemiological forecast for the total and diagnosed prevalent cases of CKD. The total and diagnosed prevalent cases of CKD are further segmented by age (18 years and older), sex, and stage (stage I, stage II, stage IIIa, stage IIIb, stage IV, and stage V) in these markets. Diagnosed prevalent cases of CKD are further segmented by dialysis-dependent (including both hemodialysis and peritoneal dialysis) and non-dialysis-dependent. The model associated with the report also provides the diagnosed prevalent cases of CKD further segmented by hyperparathyroidism, hyperphosphatemia, and hyperkalemia among dialysis-dependent and non-dialysis-dependent cases.
• The CKD epidemiology report and model were written and developed by the master- and PhD-level epidemiologists.
• The epidemiology report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
• The epidemiology model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to Buy

• The Chronic Kidney Disease Epidemiology series will allow you to:
• Develop business strategies by understanding the trends shaping and driving the global CKD market.
• Quantify patient populations in the global CKD market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for CKD therapeutics in each of the markets covered.
• Understand the magnitude of CKD population by subtype, digital vasculopathy, and other internal organ involvement.